Next Gen Sequencing: Clinical Molecular Genetics Findings
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 6914
Special Issue Editors
Interests: clinical molecular testing in hereditary and sporadic cancer
Interests: molecular diagnosis of hereditary cancer
Special Issue Information
Dear Colleagues,
Genetic testing in oncology is increasing in the clinic at a rapid pace, with thousands of clinical tests being conducted each year. Results from this testing can have serious impacts on the health of patients and their families, as well as health systems. Proper analytical pipelines, including precise variant calling and classification, are crucial for accurate interpretation of genetic testing results. Interpretation of these findings relies on both large databases as well as case findings, including those published in the literature as well as from internal-lab-generated data; therefore, sharing and publishing results from molecular testing is crucial.
This Special Issue aims to add to the current body of literature on clinical molecular findings in order to improve analytical processes, share interesting findings, and aid with the interpretation of genetic results to be able to provide the best services possible for patients. In this Special Issue, original research articles, case reports, case series, and reviews are welcome. Research areas may include (but are not limited to) the following: the development of molecular cancer testing, clinical aspects of genetic testing in cancer, or results from clinical molecular testing of the germline and/or tumors in either hereditary or sporadic cancers.
We look forward to receiving your contributions.
Dr. Leora Witkowski
Dr. Gardenia Vargas-Parra
Dr. Giovana Tardin Torrezan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- genetic testing
- molecular
- sporadic
- hereditary
- NGS
- DNA variants
- interpretation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.